G
Gary M. Onady
Researcher at Wright State University
Publications - 23
Citations - 1727
Gary M. Onady is an academic researcher from Wright State University. The author has contributed to research in topics: Health care & Evidence-based medicine. The author has an hindex of 10, co-authored 23 publications receiving 1604 citations. Previous affiliations of Gary M. Onady include Case Western Reserve University.
Papers
More filters
Journal Article
A consensus statement on health care transitions for young adults with special health care needs
Robert W. Blum,D. Hirsch,Theodore A. Kastner,R. D. Quint,Adrian D. Sandler,Susan M. Anderson,Maria T. Britto,Jan Brunstrom,Gilbert A. Buchanan,Robert Burke,John K. Chamberlain,Barbara Medoff Cooper,Daniel Davidow,Theora Evans,Thomas Gloss,Patti Hackett,Patrick Harr,William Kiernan,Eric B. Levey,Merle McPherson,Kevin Murphy,Maureen R. Nelson,Donna Gore Olson,Gary M. Onady,Betty Presler,John Reiss,Michael Rich,Peggy Mann Rinehart,David A. Rosen,Peter B Scal,David M. Siegel,Gail B. Slap,Paul Clay Sorum,Maria Veronica Svetaz,Patricia Thomas,Margaret A. Turk,Patience H. White,Philip Ziring +37 more
Journal ArticleDOI
Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society
Antoinette Moran,Carol Brunzell,Richard C. Cohen,Marcia Katz,Bruce C. Marshall,Gary M. Onady,Karen A. Robinson,Kathryn A. Sabadosa,Arlene A. Stecenko,Bonnie Slovis +9 more
TL;DR: Clinical care guidelines for cystic fibrosis–related diabetes are intended for use by CF patients, their care partners, and health care professionals and include recommendations for screening, diagnosis, and medical management of CFRD.
Journal ArticleDOI
Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials
TL;DR: Data from this meta-analysis suggest a modest role for probiotics in pediatric AD, seen in moderately severe rather than mild disease, and in children with moderately severe disease were more likely to benefit.
Journal ArticleDOI
Insulin and oral agents for managing cystic fibrosis‐related diabetes
Gary M. Onady,Adrienne Stolfi +1 more
TL;DR: To establish the effectiveness of insulin and oral agents for managing diabetes in people with cystic fibrosis in relation to blood sugar levels, lung function and weight management, randomized controlled trials comparing all methods of diabetes therapy in peopleWith diagnosed cystic Fibrosis-related diabetes are reviewed.
Journal ArticleDOI
An adult cystic fibrosis patient presenting with persistent dyspnea: case report.
TL;DR: This case report represents the first description in the medical literature of a cystic fibrosis patient diagnosed with symptomatic coronary artery disease and a standard clinical practice guide proved useful toward evaluating a differential diagnosis.